Actively Recruiting

Age: 18Years - 99Years
All Genders
Healthy Volunteers
ID06552741

Screening, Evaluation, and Assessment Protocol for Substance Use Disorder Research at NIDA Intramural Research Program

Led by National Institute on Drug Abuse (NIDA) · Updated on 2026-06-03

10000

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying people with and without alcohol and substance use disorders (ASUD) to better understand why some use drugs, stop using them, avoid addiction, or never use them at all. This observational study is conducted by the National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP) and aims to improve knowledge and develop treatments for ASUD. It focuses on evaluating participants to determine their eligibility for other ongoing research studies at NIDA. Participants will undergo a thorough screening and evaluation process lasting up to 8 hours, which may be split across multiple days depending on individual interest and study requirements. The assessments include physical exams, various biological tests (blood, saliva, urine, breath), heart function tests, smell tests, cognitive and mental health evaluations, questionnaires about substance use and medical history, and mock MRI scans. This protocol serves as the initial step to identify individuals eligible for further NIDA research studies. During the study, participants will complete one or more visits for screening and evaluation. Researchers will collect detailed data on substance use, mental and physical health, and cognitive function through tests and questionnaires. This data will be used to create a registry of potential research participants and to support future analyses aimed at understanding addiction, abstinence, and related outcomes. The study allows participation of adults aged 18 to 99 years and includes people with current, past, or no history of substance use disorders.

CONDITIONS

Brief Title

Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP

Who Can Participate

Age: 18Years - 99Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 99 years old
  • Ability to read, write, and understand English
  • Willingness to comply with all screening procedures
  • Availability for the duration of the screening period
  • Ability and willingness to sign a written informed consent document
Not Eligible

You will not qualify if you...

  • Lack of capacity to consent to research participation as determined by the Evaluation to Sign Consent (ESC)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

One or more visits

Trial Site Locations

Total: 1 location

1

National Institute on Drug Abuse

Baltimore, Maryland, United States, 21224

Actively Recruiting

Loading map...

Research Team

S

Shannon M Pfistner

L

Lorenzo Leggio, M.D.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Combined Neurofeedback-TMS Intervention for Alcohol Use Di...

Alcohol Use Disorder

Actively Recruiting

1 location

A Digital Intervention to Decrease Self-Stigma Among Pregnan...

Substance Use Disorder

Actively Recruiting

1 location

A Phase I/II Study of CMND-100 Tolerability, Safety, and Pha...

Alcohol Use Disorder

Actively Recruiting

4 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Differential Gateways, Facilitators, and Barriers to Substance Use Disorder Treatment for Pregnant Women and Mothers: A Scoping Systematic Review.

Sugy Choi, David Rosenbloom, Michael D Stein...

https://pubmed.ncbi.nlm.nih.gov/34380985

Use of a modified Clinical Institute Withdrawal Assessment (CIWA) for symptom-triggered management of alcohol withdrawal syndrome.

James Russell, Neal Richardson, Aglaja Dar

https://pubmed.ncbi.nlm.nih.gov/26026014

Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

J T Sullivan, K Sykora, J Schneiderman...

https://pubmed.ncbi.nlm.nih.gov/2597811